# Nuvectis Pharma, Inc.: Form D filing

Nuvectis Pharma, Inc., a biotechnology company in Fort Lee, NJ, filed a Form D with the SEC in 2022. The latest, on August 10, 2022, reports $15.9 million sold of a $15.9 million offering to 19 investors.

Find out what Nuvectis Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Nuvectis%20Pharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Nuvectis%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnuvectis-pharma-inc-1875558)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Nuvectis%20Pharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Nuvectis%20Pharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fnuvectis-pharma-inc-1875558)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1 BRIDGE PLAZA, SUITE 275, Fort Lee, NJ, 07024
- Phone: (201) 614-3150
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2020
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1875558

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Aug 10, 2022 | New notice | $15,878,637 | $15,878,637 | $0 | 19 | Jul 27, 2022 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1875558/000110465922088650/0001104659-22-088650-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| James Oliviero | Director |  |
| Enrique Poradosu | Executive Officer |  |
| Matthew Kaplan | Director |  |
| Michael Carson | Executive Officer |  |
| Kenneth Hoberman | Director |  |
| Ron Bentsur | Executive Officer, Director |  |
| Shay Shemesh | Executive Officer |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Aug 8, 2022](https://specstream.ai/data/form-d/week/2022-08-08) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what Nuvectis Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).